KEVIN TANG - 01 Aug 2025 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
Kevin Tang
Issuer symbol
AUPH
Transactions as of
01 Aug 2025
Transactions value $
$13,590,000
Form type
4
Filing time
05 Aug 2025, 17:31:03 UTC
Previous filing
04 Mar 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
TANG KEVIN Director 4747 EXECUTIVE DR, SUITE 210, SAN DIEGO Kevin Tang 05 Aug 2025 0001178579

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Shares Purchase $10.1M +1M +9.97% $10.12 11M 01 Aug 2025 By LP F1, F2
transaction AUPH Common Shares Purchase $1.13M +100K +0.91% $11.34 11.1M 04 Aug 2025 By LP F2, F3
transaction AUPH Common Shares Purchase $2.34M +200K +1.8% $11.68 11.3M 05 Aug 2025 By LP F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $9.23 to $10.50. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnotes 1, 3 and 4.
F2 Tang Capital Partners, LP ("TCP") beneficially owns 6,371,711 shares and Tang Capital Partners International, LP ("TCPI") beneficially owns 4,957,789 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP and TCPI.
F3 These shares were purchased in multiple transactions ranging from $11.11 to $11.48.
F4 These shares were purchased in multiple transactions ranging from $11.49 to $11.80.